Cargando…

A tumor-associated endothelial signature score model in immunotherapy and prognosis across pan-cancers

Background: The tumor-associated endothelial cell (TAE) component plays a vital role in tumor immunity. However, systematic tumor-associated endothelial-related gene assessment models for predicting cancer immunotherapy (CIT) responses and survival across human cancers have not been explored. Herein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Shuzhao, Zhang, Limei, Huang, Mayan, Liang, Yang, Wang, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500301/ https://www.ncbi.nlm.nih.gov/pubmed/37719845 http://dx.doi.org/10.3389/fphar.2023.1190660

Ejemplares similares

Comprehensive analysis of glycoprotein VI-mediated platelet activation signaling pathway for predicting pan-cancer survival and response to anti-PD-1 immunotherapy
por: Chen, Shuzhao, et al.
Publicado: (2023)

Inflammatory and Nutritional Scoring System for Predicting Prognosis in Patients with Newly Diagnosed Multiple Myeloma
por: Zhang, Limei, et al.
Publicado: (2023)

Systematic analysis of the necroptosis index in pan-cancer and classification in discriminating the prognosis and immunotherapy responses of 1716 glioma patients
por: Ma, Shuai, et al.
Publicado: (2023)

Prognostic value of the nutritional risk index in patients with newly diagnosed multiple myeloma
por: Zhang, Limei, et al.
Publicado: (2022)

NMI: a potential biomarker for tumor prognosis and immunotherapy
por: He, Teng, et al.
Publicado: (2022)

A combined aging and immune prognostic signature predict prognosis and responsiveness to immunotherapy in melanoma
por: Lv, Wenchang, et al.
Publicado: (2022)

Functional Gene Expression Signatures from On-Treatment Tumor Specimens Predict Anti-PD1 Blockade Response in Metastatic Melanoma
por: Chen, Shuzhao, et al.
Publicado: (2022)

Deciphering the role of NETosis-related signatures in the prognosis and immunotherapy of soft-tissue sarcoma using machine learning
por: Qi, Lin, et al.
Publicado: (2023)

Pan-Cancer Analysis of the Characteristics of LY96 in Prognosis and Immunotherapy Across Human Cancer
por: Nie, Kechao, et al.
Publicado: (2022)

ICD-related risk model predicts the prognosis and immunotherapy response of patients with liver cancer
por: Su, Duntao, et al.
Publicado: (2023)

Identification of a novel ferroptosis-related gene signature associated with prognosis, the immune landscape, and biomarkers for immunotherapy in ovarian cancer
por: Liu, Yilong, et al.
Publicado: (2022)

Identification and validation of a novel cuproptosis-related genes signature associated with prognosis, clinical implications and immunotherapy of hepatocellular carcinoma
por: He, Fengjiao, et al.
Publicado: (2023)

Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
por: Li, Chong, et al.
Publicado: (2023)

The pyroptosis-related gene signature predicts prognosis and reveals characterization of the tumor immune microenvironment in acute myeloid leukemia
por: Zhou, Tao, et al.
Publicado: (2022)

Serine and glycine metabolism-related gene expression signature stratifies immune profiles of brain gliomas, and predicts prognosis and responses to immunotherapy
por: Chen, Siliang, et al.
Publicado: (2022)

Identification of Potential Biomarkers for Pan-Cancer Diagnosis and Prognosis Through the Integration of Large-Scale Transcriptomic Data
por: Zhu, Lin, et al.
Publicado: (2022)

Molecular characterization based on tumor microenvironment-related signatures for guiding immunotherapy and therapeutic resistance in lung adenocarcinoma
por: Jie, Yamin, et al.
Publicado: (2023)

TCR Coexpression Signature Predicts Immunotherapy Resistance in NSCLC
por: Wang, Yuntao, et al.
Publicado: (2022)

An anoikis-based signature for predicting prognosis in hepatocellular carcinoma with machine learning
por: Guizhen, Zhang, et al.
Publicado: (2023)

HIPPO signaling-related signature for predicting prognosis and therapeutic response in gastric cancer
por: Jiang, Rui, et al.
Publicado: (2023)

URB2 as an important marker for glioma prognosis and immunotherapy
por: Fang, Chaoyou, et al.
Publicado: (2023)

A novel defined risk signature of cuproptosis-related long non-coding RNA for predicting prognosis, immune infiltration, and immunotherapy response in lung adenocarcinoma
por: Ma, Chao, et al.
Publicado: (2023)

Integrated single-cell and transcriptome sequencing analyses develops a metastasis-based risk score system for prognosis and immunotherapy response in uveal melanoma
por: Meng, Shuting, et al.
Publicado: (2023)

A transcriptomic pan-cancer signature for survival prognostication and prediction of immunotherapy response based on endothelial senescence
por: Wu, Zhengquan, et al.
Publicado: (2023)

Pan-Cancer Analysis Reveals Alternative Splicing Characteristics Associated With Immune-Related Adverse Events Elicited by Checkpoint Immunotherapy
por: He, Xiujing, et al.
Publicado: (2021)

Predicting the Prognosis of Esophageal Adenocarcinoma by a Pyroptosis-Related Gene Signature
por: Zeng, Ruijie, et al.
Publicado: (2021)

The role of Angiogenesis and remodeling (AR) associated signature for predicting prognosis and clinical outcome of immunotherapy in pan-cancer
por: Sun, Xiaojiao, et al.
Publicado: (2022)

Systematic analysis reveals a pan-cancer SNHG family signature predicting prognosis and immunotherapy response
por: Zheng, Haotian, et al.
Publicado: (2023)

SLC11A1 associated with tumor microenvironment is a potential biomarker of prognosis and immunotherapy efficacy for colorectal cancer
por: Ma, Yiming, et al.
Publicado: (2022)

Identification of anoikis-related molecular patterns to define tumor microenvironment and predict immunotherapy response and prognosis in soft-tissue sarcoma
por: Qi, Lin, et al.
Publicado: (2023)

Prognosis prediction and tumor immune microenvironment characterization based on tryptophan metabolism-related genes signature in brain glioma
por: Zhang, Shuxin, et al.
Publicado: (2022)

Role of PRDM1 in Tumor Immunity and Drug Response: A Pan-Cancer Analysis
por: Shen, Lujun, et al.
Publicado: (2020)

Characterization of lung adenocarcinoma based on immunophenotyping and constructing an immune scoring model to predict prognosis
por: Liu, Mengfeng, et al.
Publicado: (2022)

Pan-cancer analysis of Homeobox B9 as a predictor for prognosis and immunotherapy in human tumors
por: Jin, Qingdong, et al.
Publicado: (2023)

A novel score system based on arginine metabolism-related genes to predict prognosis, characterize immune microenvironment, and forecast response to immunotherapy in IDH-wildtype glioblastoma
por: Feng, Wentao, et al.
Publicado: (2023)

Integrated multi-omics identified the novel intratumor microbiome-derived subtypes and signature to predict the outcome, tumor microenvironment heterogeneity, and immunotherapy response for pancreatic cancer patients
por: Zhang, Biao, et al.
Publicado: (2023)

Construction of anoikis-related lncRNAs risk model: Predicts prognosis and immunotherapy response for gastric adenocarcinoma patients
por: Li, Qinglin, et al.
Publicado: (2023)

Ginsenosides: Allies of gastrointestinal tumor immunotherapy
por: Feng, Yutao, et al.
Publicado: (2022)

Systematic evaluation of tumor microenvironment and construction of a machine learning model to predict prognosis and immunotherapy efficacy in triple-negative breast cancer based on data mining and sequencing validation
por: Gou, Qiheng, et al.
Publicado: (2022)

Identification of lncRNA Signature of Tumor-Infiltrating T Lymphocytes With Potential Implications for Prognosis and Chemotherapy of Head and Neck Squamous Cell Carcinoma
por: Wang, Liping, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_87540q5pvj1nubgscobf3tpcld